Community-acquired pneumonia. Common pathogens and antimicrobial resistance;Ambulant erworbene Pneumonie Häufige Erreger und Antibiotikaresistenz

Pneumologe

Volumn 2, Issue 1, 2005, Pages 17-27

  Pletz, M W R ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Antimicrobial resistance; Community acquired pneumonia; Etiology; Streptococcus pneumoniae; Vaccination

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL PROTOCOL; COMMUNITY ACQUIRED PNEUMONIA; FRANCE; GEOGRAPHIC DISTRIBUTION; GERMANY; GREECE; HAEMOPHILUS INFLUENZAE; HUMAN; INFECTION RISK; MYCOPLASMA PNEUMONIAE; PRACTICE GUIDELINE; RISK FACTOR; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 13644272603     PISSN: 16135636     EISSN: 16136055     Source Type: Journal    
DOI: 10.1007/s10405-004-0019-7     Document Type: Article

References (24)

1. Burkhardt O, Straube E, Welte T (2003) Klinisches Bild, Diagnose und Therapie der Chlamydien-Pneumonie. Pneumologie 57 (8):449-458. 10.1055/s-2003-41550
2. Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D et al. (1997) Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study. Clin Infect Dis 24 (6):1052-1059. 1:STN:280:ByiA3sfkvFM%3D
3. Ewig S, Reinert RR, Wiedemann B et al. (2002) Antibiotika-Resistenz bei Erregern ambulant erworbener Atemwegsinfektionen: Ergebnisse eines Experten-Workshops am 11. Juni 2001 in Berlin (The role of antimicrobial resistance in communtiy acquired respiratory tract infections). Chemother J 11:12-26
4. Feldman C (2004) Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med 143 (5):269-283. 10.1016/j.lab.2004.02.002
5. Ferraro MJ (2001) Should we reevaluate antibiotic breakpoints? Clin Infect Dis 33 [Suppl 3]:S227-229
6. File TM (2003) Community-acquired pneumonia. Lancet 362 (9400):1991-2001. 10.1016/S0140-6736(03)15021-0
7. Hakenbeck R, Balmelle N, Weber B et al. (2001) Mosaic genes and mosaic chromosomes: Intra- and interspecies genomic variation of Streptococcus pneumoniae. Infect Immun 69 (4):2477-2486. 10.1128/IAI.69.4.2477-2486.2001
8. Ho PL, Yam WC, Cheung TK et al. (2001) Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone. Emerg Infect Dis 7 (5):906-908. 1:STN:280:DC%2BD3MnpvFShsw%3D%3D
9. Jones ME, Blosser-Middleton RS, Critchley IA et al. (2003) In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: A European multicenter study during 2000-2001. Clin Microbiol Infect 9 (7):590-599. 10.1046/j.1469-0691.2003.00573.x
10. Jones ME, Blosser-Middleton RS, Thornsberry C et al. (2003) The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002. Diagn Microbiol Infect Dis 47 (4):579-586. 10.1016/S0732-8893(03)00140-8
11. Kiso M, Mitamura K, Sakai-Tagawa Y et al. (2004) Resistant influenza A viruses in children treated with oseltamivir: Descriptive study. Lancet 364 (9436):759-765. 10.1016/S0140-6736(04)16934-1
12. Klugman KP (2002) The successful clone: The vector of dissemination of resistance in Streptococcus pneumoniae. J Antimicrob Chemother 50 [Suppl S2]:1-5
13. McGee L, McDougal L, Zhou J et al. (2001) Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol 39 (7):2565-2571. 10.1128/JCM.39.7.2565-2571.2001
14. Niedermann M (2004) Review of treatment guidelines for community-acquired pneumonia. Am J Med 117 [Suppl 3A]:51S-57S
15. Nuermberger E, Bishai WR (2004) The clinical significance of macrolide-resistant Streptococcus pneumoniae: It's all relative. Clin Infect Dis 38 (1):99-103. 10.1086/380126
16. Pletz MW, McGee L, Jorgensen J et al. (2004) Levofloxacin-resistant invasive streptococcus pneumoniae in the United States: Evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother 48 (9):3491-3497. 10.1128/AAC.48.9.3491-3497.2004
17. Reinert RR, Muckel S, Al-Lahham A et al. (2003) Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing. J Med Microbiol 52 (Pt 11):981-987. 10.1099/jmm.0.05216-0
18. Reinert RR, Franken C, van der Linden M et al. (2004) Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003 Int J Antimicrob Agents 24 (1):43-47. 10.1016/j.ijantimicag.2004.02.020
19. Reinert RR, Lutticken R, Reinert S et al. (2004) Antimicrobial resistance of streptococcus pneumoniae isolates of outpatients in Germany, 1999-2000. Chemotherapy 50 (4):184-189. 10.1159/000080692
20. Reinert RR, Rodloff AC, Halle E et al. (2004) Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: Results from the PROTEKT surveillance study (1999-2000). Chemotherapy 50 (3):143-151
21. Ruiz-Gonzalez A, Falguera M, Nogues A, Rubio-Caballero M (1999) Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am J Med 106 (4):385-390. 10.1016/S0002-9343(99)00050-9
22. Scheld WM (2003) Maintaining fluoroquinolone class efficacy: Review of influencing factors. Emerg Infect Dis 9 (1):1-9. 1:CAS:528:DC%2BD3sXhtVGrsrc%3D
23. Waites KB, Rikihisa Y, Taylor-Robinson D (2003) Mycoplasma and ureaplasma. In: Murray PR, Barron EJ, Jorgensen JH et al. (eds) Manual of clinical microbiology, 8th edn. American Society for Microbiology, Washington, pp 972-990
24. Woodhead M (1998) Community-acquired pneumonia guidelines - an international comparison: A view from Europe. Chest 113 [3 Suppl]:183S-187S